This inventor holds 1 USPTO granted patent. Top assignees: Florida Memorial University, University of Kansas. Active years: 2014.
Company Filing History:
1 out of 1 
1 out of 571 
Years Active: 2014
Title: **The Innovative Journey of Sarah Sullivan: A Pioneer in PEPCK Inhibitors**
Introduction
Sarah Sullivan, an accomplished inventor based in Wallenstein, California, has made significant contributions to the field of enzyme inhibition. With a robust patent portfolio, she is recognized for her innovative approach to developing inhibitors targeting the enzyme phosphoenolpyruvate carboxykinase (PEPCK). Her pioneering work has the potential to advance therapeutic strategies in various medical applications.
Latest Patents
Sullivan holds a patent for an "Inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase." This patent describes a PEPCK inhibitor that involves identifying a molecule capable of fitting and interacting with the PEPCK binding site. Notably, the innovation hinges on the inclusion of specific structural features, such as a first terminal substituent with co-planar atoms acting as metal ligands, and diverse substituents positioned strategically to enhance binding affinity and inhibition efficacy.
Career Highlights
Throughout her career, Sarah Sullivan has worked at prestigious institutions, including the University of Kansas and Florida Memorial University. These environments have fostered her passion for research while providing invaluable opportunities to enhance her expertise in the biochemical sciences. Her dedication and innovation have made her a notable figure in her field.
Collaborations
Sullivan has collaborated with prominent colleagues in her research pursuits, including Gerald Carlson and Todd Holyoak. These partnerships have enhanced her research capabilities and contributed to the development of innovative solutions in enzyme inhibition and related areas.
Conclusion
Sarah Sullivan's journey as an inventor embodies the spirit of innovation essential for advancing scientific knowledge. Her work on PEPCK inhibitors not only showcases her technical expertise but also her commitment to exploring new frontiers in medicine. With her ongoing contributions to the field, she stands as a beacon of inspiration for current and future generations of inventors and researchers.